Cadila gets approval for Rp50bn QIP
Indian company Cadila Healthcare is gearing up for a Rp50bn ($741.1m) qualified institutional placement after the country’s Foreign Investment Promotion Board gave it the go ahead this week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts